Run Pharmacy Look-Alike Sound-Alike Medication Audit — Free

Audit Scope and Documentation

Current LASA medication list is available and reviewed critical (required)

A current, site-specific list of look-alike/sound-alike medication pairs is available for the audit and reflects recent formulary or stocking changes.

Yes No N/A

High-risk or frequently confused medications are identified critical (required)

Medications with similar names, packaging, strengths, or dosage forms are identified and prioritized for control review.

Yes No N/A

Audit references current SOPs and storage standards

The audit references current pharmacy SOPs, labeling standards, and relevant storage/fire-life-safety requirements applicable to the area inspected.

Yes No N/A

Recent incidents, near-misses, or trend data reviewed

Recent LASA-related incidents, near-misses, or quality trend data were reviewed to focus the inspection on known risk points.

Yes No N/A

Inspection area and date documented

The specific pharmacy area, storage location, and inspection date are documented for traceability.

Tall Man Lettering and Label Clarity

Tall Man lettering used consistently on LASA labels critical (required)

Tall Man lettering is applied consistently to medication labels, shelf labels, bin labels, and other visual controls for identified LASA pairs.

Yes No N/A

Label text is legible at point of selection critical (required)

Medication names, strengths, and auxiliary warnings are legible at the point where staff select the product.

Yes No N/A

Strength and dosage form are clearly differentiated critical (required)

Labels clearly distinguish strength and dosage form for products with similar names or packaging.

Yes No N/A

Auxiliary warnings or caution labels present where needed

Auxiliary warnings are used when they reduce selection risk, such as warnings for different concentrations, routes, or formulations.

Yes No N/A

Labeling does not obscure critical information

Tall Man lettering, warning labels, and barcodes do not obscure the drug name, strength, expiration date, or other critical information.

Yes No N/A

Physical Separation and Storage Controls

Confusable medications are physically separated critical (required)

Look-alike/sound-alike medications are stored in separate bins, shelves, drawers, or locations to reduce the chance of selection error.

Yes No N/A

High-alert LASA medications are segregated from routine stock critical (required)

High-alert or frequently confused medications are segregated from routine stock and not stored adjacent to similarly named products.

Yes No N/A

Shelf/bin organization prevents adjacent placement of similar names critical (required)

Adjacent storage does not place similar names, packaging, or strengths side by side without a physical or visual barrier.

Yes No N/A

Storage bins are labeled with clear location identifiers

Bins, shelves, and drawers are labeled so staff can quickly verify the correct product location before selection.

Yes No N/A

Expired, quarantined, or returned stock is segregated critical (required)

Expired, quarantined, or returned medications are stored separately from active stock and are clearly identified to prevent inadvertent use.

Yes No N/A

Dispensing and Workflow Safeguards

Independent double-check required for selected LASA items critical (required)

A second-person verification or independent double-check is required for designated LASA or high-risk medications where applicable.

Yes No N/A

Barcode or electronic verification used when available

Barcode scanning or electronic verification is used to confirm product identity when available in the workflow.

Yes No N/A

Look-alike products are not repackaged without added safeguards

If repackaging occurs, the process includes controls that preserve clear identification and prevent confusion with similar products.

Yes No N/A

Picking area minimizes distractions and interruptions

The medication selection area is organized to minimize interruptions, clutter, and distractions that could contribute to selection errors.

Yes No N/A

Separate storage used for look-alike oral liquids or injectables

Similar oral liquids, injectables, or concentrated formulations are stored with additional safeguards when the risk of mix-up is elevated.

Yes No N/A

Staff Awareness and Corrective Actions

Staff can describe LASA controls in the area

Staff interviewed can describe the local controls used to prevent look-alike/sound-alike selection errors.

Yes No N/A

Deficiencies documented with corrective action owner and due date critical (required)

Any deficiency or non-conformance is documented with a responsible owner and target completion date.

Yes No N/A

Repeat issues escalated through quality or safety process

Repeat LASA issues are escalated through the pharmacy quality, safety, or management review process for trend analysis and prevention.

Yes No N/A

Inspector signature critical (required)

Inspector signs to confirm the audit findings and any documented deficiencies.

Get your results

Enter your email — we'll send you a PDF of your filled-out template, plus the occasional MangoScoop newsletter (templates, workflow tips, product updates). Unsubscribe anytime — link is in every email.

Email (required)

Your name (optional)

Run: Pharmacy Look-Alike Sound-Alike Medication Audit

Audit Scope and Documentation

Tall Man Lettering and Label Clarity

Physical Separation and Storage Controls

Dispensing and Workflow Safeguards

Staff Awareness and Corrective Actions

Get your results